Loading insider details...
Latest Form 4 (Nov 16, 2026): Sale of 1,991 DYN shares, $33.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 16, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 1,991 | $33.5K |
| Aug 17, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 1,797 | $47.2K |
| Jun 26, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,362 | $48.1K |
| May 14, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 1,448 | $26.6K |
| Apr 3, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 5,727 | $106.8K |
| Feb 17, 2026 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 65,000 | n/a |
| Dec 18, 2025 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 150,000 | n/a |
| Nov 7, 2025 | Beyond Air, Inc. (XAIR) | Disposition to Issuer | 2,250 | n/a |
| Apr 1, 2025 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 66,100 | n/a |
| Mar 28, 2025 | Beyond Air, Inc. (XAIR) | Grant/Award | 75,000 | n/a |